These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12584574)

  • 21. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
    Honorio S; Agathanggelou A; Wernert N; Rothe M; Maher ER; Latif F
    Oncogene; 2003 Jan; 22(3):461-6. PubMed ID: 12545168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
    Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma.
    Tomizawa Y; Kohno T; Kondo H; Otsuka A; Nishioka M; Niki T; Yamada T; Maeshima A; Yoshimura K; Saito R; Minna JD; Yokota J
    Clin Cancer Res; 2002 Jul; 8(7):2362-8. PubMed ID: 12114441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
    Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
    Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.
    Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP
    Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma.
    Macheiner D; Heller G; Kappel S; Bichler C; Stättner S; Ziegler B; Kandioler D; Wrba F; Schulte-Hermann R; Zöchbauer-Müller S; Grasl-Kraupp B
    J Hepatol; 2006 Jul; 45(1):81-9. PubMed ID: 16516329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma.
    Dammann R; Schagdarsurengin U; Liu L; Otto N; Gimm O; Dralle H; Boehm BO; Pfeifer GP; Hoang-Vu C
    Oncogene; 2003 Jun; 22(24):3806-12. PubMed ID: 12802288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer.
    Irimia M; Fraga MF; Sanchez-Cespedes M; Esteller M
    Oncogene; 2004 Nov; 23(53):8695-9. PubMed ID: 15378027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic inactivation of the NORE1 gene correlates with malignant progression of colorectal tumors.
    Lee CK; Lee JH; Lee MG; Jeong SI; Ha TK; Kang MJ; Ryu BK; Hwangbo Y; Shim JJ; Jang JY; Lee KY; Kim HJ; Chi SG
    BMC Cancer; 2010 Oct; 10():577. PubMed ID: 20969767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent epigenetic inactivation of the SLIT2 gene in gliomas.
    Dallol A; Krex D; Hesson L; Eng C; Maher ER; Latif F
    Oncogene; 2003 Jul; 22(29):4611-6. PubMed ID: 12881718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequent hypermethylation of the RASSF1A gene in prostate cancer.
    Liu L; Yoon JH; Dammann R; Pfeifer GP
    Oncogene; 2002 Oct; 21(44):6835-40. PubMed ID: 12360410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
    Clin Cancer Res; 2003 Apr; 9(4):1441-5. PubMed ID: 12684417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.
    Agathanggelou A; Honorio S; Macartney DP; Martinez A; Dallol A; Rader J; Fullwood P; Chauhan A; Walker R; Shaw JA; Hosoe S; Lerman MI; Minna JD; Maher ER; Latif F
    Oncogene; 2001 Mar; 20(12):1509-18. PubMed ID: 11313894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells.
    Dallol A; Morton D; Maher ER; Latif F
    Cancer Res; 2003 Mar; 63(5):1054-8. PubMed ID: 12615722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.
    Ito M; Ito G; Kondo M; Uchiyama M; Fukui T; Mori S; Yoshioka H; Ueda Y; Shimokata K; Sekido Y
    Cancer Lett; 2005 Jul; 225(1):131-9. PubMed ID: 15922865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A.
    Macheiner D; Gauglhofer C; Rodgarkia-Dara C; Grusch M; Brachner A; Bichler C; Kandioler D; Sutterlüty H; Mikulits W; Schulte-Hermann R; Grasl-Kraupp B
    Cancer Res; 2009 Jan; 69(1):235-42. PubMed ID: 19118008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma.
    Schagdarsurengin U; Wilkens L; Steinemann D; Flemming P; Kreipe HH; Pfeifer GP; Schlegelberger B; Dammann R
    Oncogene; 2003 Mar; 22(12):1866-71. PubMed ID: 12660822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ
    Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
    Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
    Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.